NAOV - NanoVibronix, Inc.
| Previous Close | 4.23 |
| Open | 4.20 |
| Bid | 3.80 x 800 |
| Ask | 4.25 x 3200 |
| Day's Range | 4.20 - 4.25 |
| 52 Week Range | 3.68 - 7.20 |
| Volume | 1,365 |
| Avg. Volume | 5,945 |
| Market Cap | 27.247M |
| Beta (3Y Monthly) | 0.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.62 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•2 months ago
NanoVibronix Provides Business Update for the Second Quarter of 2018
NanoVibronix, Inc, (NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the second quarter ended June 30, 2018. Brian Murphy, Chief Executive Officer of NanoVibronix, commented, "We believe our commercial strategy is beginning to take hold, as reflected by a 153% increase in sales, albeit off a small base, as our initial distributors have begun marketing our products in their respective markets. In June, we announced that we entered into another distribution agreement with M.D.S. Pharm Ltd. to market and distribute PainShield® and WoundShield® in Israel.
- GlobeNewswire•3 months ago
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
NanoVibronix, Inc, (NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful results for its PainShield™ device in treating patients with Trigeminal Neuralgia. PainShield™ is an ultrasound-based product that is designed to treat pain in nerves, muscles, joints and soft tissue through delivery of a localized ultrasound, and induces soft tissue healing in targeted areas. PainShield™ has received 510(k) clearance from the U.S. Food and Drug Administration, CE Mark approval in Europe, and Health Canada approval. PainShield™ is available online at www.nanovibronix.com and through select distributors. Trigeminal Neuralgia, also known as prosopalgia, suicide disease, or Fothergill’s disease is a neuropathic disorder characterized by episodes of intense pain in the face, originating from the trigeminal nerve.
- ACCESSWIRE•5 months ago
NanoVibronix to Present at the 8th Annual LD Micro Invitational Conference
ELMSFORD, NY / ACCESSWIRE / June 1, 2018 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, ...
- Simply Wall St.•5 months ago
Who Are NanoVibronix Inc’s (NASDAQ:NAOV) Major Shareholders?
In this article, I’m going to take a look at NanoVibronix Inc’s (NASDAQ:NAOV) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors.Read More...
- Marketwired•7 months ago
NanoVibronix Announces Instrumed Surgical as its Exclusive Canadian Distributor for UroShield(TM)
NanoVibronix, Inc. , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced it has signed Instrumed Surgical of Mississauga, ...
- Marketwired•7 months ago
NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today provided a business update for the year ended December ...
- Marketwired•7 months ago
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera Appear on Fox News Radio's The Brian Kilmeade Show to Discuss PainShield's Advantages and Potential to Reduce Opioid Use
NanoVibronix Inc. , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced that Brian Murphy, CEO of NanoVibronix and ...
- Marketwired•7 months ago
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's Mornings with Maria to Discuss the Role of PainShield in Fighting the Opioid Epidemic
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced that Brian Murphy, CEO of NanoVibronix and ...
- Simply Wall St.•7 months ago
NanoVibronix Inc’s (NASDAQ:NAOV) Earnings Dropped -78.33%, How Did It Fare Against The Industry?
Assessing NanoVibronix Inc’s (NASDAQ:NAOV) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check to buildRead More...
- Marketwired•8 months ago
NanoVibronix Announces Positive Response to UroShield(TM) Presentation at the Infection Prevention and Control 2018 London Conference
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology today announced that Dr. Harold Jacob, M.D., Chief Medical ...
- Marketwired•9 months ago
NanoVibronix to Present at the 14th Annual Noble Capital Markets Investor Conference
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, will present at NobleCon14 - Noble Capital Markets' Fourteenth ...
- Marketwired•9 months ago
NanoVibronix CEO Brian Murphy Appears on Varney & Co. on Fox Business; Comments on Role of PainShield in Fighting Opioid Epidemic
NanoVibronix, Inc., , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared ...
- Simply Wall St.•9 months ago
Breaking Down NanoVibronix Inc’s (NASDAQ:NAOV) Ownership Structure
In this article, I will take a quick look at NanoVibronix Inc’s (NASDAQ:NAOV) recent ownership structure – an unconventional investing subject, but an important one. When it comes to ownershipRead More...
- Simply Wall St.•10 months ago
What Did NanoVibronix Inc’s (NASDAQ:NAOV) CEO Take Home Last Year?
Brian Murphy took the helm as NanoVibronix Inc’s (NASDAQ:NAOV) CEO and grew market cap to $17.40M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial part ofRead More...
- Simply Wall St.•10 months ago
Is NanoVibronix Inc (NASDAQ:NAOV) On The Right Side Of Disruption?
NanoVibronix Inc (NASDAQ:NAOV), a USD$17.36M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as anRead More...
- Marketwired•10 months ago
NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today provided the following business update and letter to ...
- Marketwired•10 months ago
NanoVibronix Announces Morulaa HealthTech as its Regulatory & Marketing Partner in India
NanoVibronix, Inc, , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced it has signed Morulaa HealthTech as its regulatory ...
- Marketwired•10 months ago
NanoVibronix Announces IMS Ultrasound (UK) Ltd as its Exclusive UK Distributor for UroShield(TM) Following Successful Interim Trial Results
NanoVibronix, Inc., , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave technology, today announced it has signed IMS Ultrasound Ltd as its exclusive ...
- Simply Wall St.•10 months ago
Where NanoVibronix Inc (NAOV) Stands In Terms Of Earnings Growth Against Its Industry
In this article, I will take a look at NanoVibronix Inc’s (NASDAQ:NAOV) most recent earnings update (30 September 2017) and compare these latest figures against its performance over the pastRead More...
